<code id='D82B394513'></code><style id='D82B394513'></style>
    • <acronym id='D82B394513'></acronym>
      <center id='D82B394513'><center id='D82B394513'><tfoot id='D82B394513'></tfoot></center><abbr id='D82B394513'><dir id='D82B394513'><tfoot id='D82B394513'></tfoot><noframes id='D82B394513'>

    • <optgroup id='D82B394513'><strike id='D82B394513'><sup id='D82B394513'></sup></strike><code id='D82B394513'></code></optgroup>
        1. <b id='D82B394513'><label id='D82B394513'><select id='D82B394513'><dt id='D82B394513'><span id='D82B394513'></span></dt></select></label></b><u id='D82B394513'></u>
          <i id='D82B394513'><strike id='D82B394513'><tt id='D82B394513'><pre id='D82B394513'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:6
          Limor Appelbaum, radiation oncologist and a researcher working on the effort to predict pancreatic cancer for early detection, using AI analysis of vast amounts of electronic health records. -- health coverage from STAT
          Suzanne Kreiter/Globe staff

          Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late.

          Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.

          advertisement

          Only 11 percent of people diagnosed with pancreatic cancer are alive five years later.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Listen: Biogen's potential pivot, & Illumina's next chapter
          Listen: Biogen's potential pivot, & Illumina's next chapter

          Aretherestilltoomanybiotechcompanies?Howdoyouknowwhenyou’reinabubble?Andisthereawrongwaytopronounce“

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          How to fix cancer clinical trials' diversity problem

          Clockwisefromtopleft:STAT'sNicholasSt.Fleur(moderator);JudySewards,headofclinicaltrialexperienceatPf